Namely, the selective anoctamin-1 inhibitor T16Ainh-A01 was less effective than CaCCinh-A01, which inhibits anoctamin-1 and other CaCCs, suggesting that activation of other CaCCs besides anoctamin-1 contribute to inducing neuropathic pain. Here, ANO1 is linked to neuropathic pain.